BOLT fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies deals with advanced medical devices, medication, diagnostics, and digital healthcare. BioLight's portfolio includes: DiagnosTear's TeaRx, LipiCare, ViSci, OphRx, Peripherex, AEYE, Tarsier, Belkin Vision, and Sanoculis. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
BOLT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company